The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancer

BACKGROUND: The study investigated the resistant pattern and clinical outcomes of epidermal growth factor receptor (EGFR) exon 19 deletion (19del) subtypes to tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC). METHODS: Two hundred eight treatment naive NSCLC patients detected a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chao, Jiang, Tao, Li, Jiayu, Wang, Yan, Su, Chunxia, Chen, Xiaoxia, Ren, Shengxiang, Li, Xuefei, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481579/
https://www.ncbi.nlm.nih.gov/pubmed/32953493
http://dx.doi.org/10.21037/tlcr-19-359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481579/
https://www.ncbi.nlm.nih.gov/pubmed/32953493
http://dx.doi.org/10.21037/tlcr-19-359

Ejemplares similares